Munir is an advisor or consultant for Alexion, AstraZeneca, BeiGene, Janssen, Lilly, MorphoSys, Roche, Sobi, and Sunesis; has received research grants from AbbVie ...

Wendtner has served on advisory boards for AbbVie, Amgen, Astra­zeneca, BeOne Medicines, BIONTech, Cllag-Janssen, F. Hoffmann-La Roche, Genentech, Gilead, GSK ...

Chronic lymphocytic leukemia (CLL) is the most common leukemia in adult patients living in the western hemisphere. The annual incidence of CLL is 4.2/100 000 people, with median (interquartile range ...

An interim analysis of progression-free survival in this trial showed that ibrutinib–venetoclax was superior to fludarabine–cyclophosphamide–rituximab (FCR) among patients with chronic lymphocytic ...

This, of course, does not indicate that there is no need for better proposals that could improve our ability to diagnose CLL and, more importantly, to better classify an imprecise group of B-LPD named ...

Whether fixed-duration acalabrutinib–venetoclax (with or without obinutuzumab) would result in better progression-free survival than chemoimmunotherapy in patients with untreated chronic lymphocytic ...

The treatment of chronic lymphocytic leukemia (CLL) consists of the continuous use of Bruton tyrosine kinase inhibitors (BTKis) such as ibrutinib, acalabrutinib, zanubrutinib and pirtobrutinib, or Bcl ...

Contributed by Albert de la Chapelle, February 24, 2015 (sent for review January 28, 2015; reviewed by Megan S. Lim and Adrian Wiestner) Concordance of V gene prediction and percent mutation between ...

Pull requests help you collaborate on code with other people. As pull requests are created, they’ll appear here in a searchable and filterable list. To get started, you should create a pull request.

Association between treatment (tx) response and PFS and OS in R/R chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL): A 12-month landmark (LM) meta-analysis.

Cancer is associated intimately with inflammation. Two major nodes of inflammation are regulated, respectively, by interleukin-1 (IL-1) via the transcription factor NFκB and type 1 interferon (IFN) ...